Policy Notices

• Updated Guidance for Videos Submitted as NIH Application Materials
  (NOT-OD-20-061)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  

• Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2020
  (NOT-OD-20-065)
  National Institutes of Health
  

• Notice of Legislative Mandates in Effect for FY 2020
  (NOT-OD-20-066)
  National Institutes of Health
  

• Notice of Fiscal Policies in Effect for FY 2020
  (NOT-OD-20-068)
  National Institutes of Health
  

• Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2020
  (NOT-OD-20-070)
  National Institutes of Health
  

General Notices

• Notice of Extension of the Response Date for NOT-HL-19-729 "Request for Information (RFI) on Opportunities for Promoting Cardiovascular Health of Mothers and Children through Evidence-based Maternal, Infant, and Early Childhood Home Visiting Programs"
  (NOT-HL-20-754)
  National Heart, Lung, and Blood Institute
  

• Notice of NIH Pre-Application Webinar for RFA-NS-20-028 "HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)".
  (NOT-NS-20-027)
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• Notice of Extension of the Response Date to NOT-OD-20-050 "Request for Information (RFI): FY 2021-2025 Strategic Plan for the Office of Research Infrastructure Programs: Division of Comparative Medicine and Division of Construction and Instruments Program
  (NOT-OD-20-067)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Notice of Changes to Funding Opportunities

• Notice of NIEHS Participation in RFA-OD-20-007 "Development of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C)
  (NOT-ES-20-010)
  National Institute of Environmental Health Sciences
  

• Notice of Change to first AIDS Application Due Date in PAR-20-078 "Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)"
  (NOT-HL-20-751)
  National Heart, Lung, and Blood Institute
  

• Notice to Extend the Response Date for NOT- TW-19-008 Request for Information Learning from the Transfer of HIV Interventions from Low- and Middle-Income Countries (LMICs) to the United States: Informing the Plan for America to End the HIV Epidemic
  (NOT-TW-19-009)
  John E. Fogarty International Center
  

Notices of Special Interest

• RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
  (NOT-AI-20-030)
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders
  (NOT-DA-20-013)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders
  (NOT-DA-20-031)
  National Institute on Drug Abuse
  

• Notice of Special Interest(NOSI): HEAL Initiative: Social Network Analyses to Reduce American Indian and Alaska Native Opioid Use Disorder and Related Risks for Suicide and Mental Health Disorders
  (NOT-DA-20-033)
  National Institute on Drug Abuse
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Special Interest(NOSI): Availability of Administrative Supplements for Equipment Purchases for NIGMS Awardees
  (NOT-GM-20-013)
  National Institute of General Medical Sciences
  

• Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
  (NOT-HG-20-017)
  National Human Genome Research Institute
  

• Notice of Special Interest: HEAL Supplements to Improve the Treatment and Management of Common Co-occurring Conditions and Suicide Risk in People Affected by the Opioid Crisis
  (NOT-MH-20-025)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Behavioral and Social Sciences Research
  

Funding Opportunities

• Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)
  (PAR-20-098)
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020
  
  

• Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)
  (PAR-20-104)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 26, 2020; January 26, 2021; May 26, 2021; January 26, 2022; May 26, 2022; January 26, 2023
  
  

• Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed
  (PAR-20-105)
  Food and Drug Administration
  Application Receipt Date(s): May 6, 2020 by 11:59 PM Eastern Time April 6, 2021 by 11:59 PM Eastern Time. April 6, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-20-106)
  National Institute of Allergy and Infectious Diseases
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-20-107)
  National Institute of Allergy and Infectious Diseases
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
  (PAR-20-108)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 15, 2020; July 15, 2021; July 15 2022
  
  

• Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)
  (PAR-20-109)
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020
  
  

• National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed)
  (PAR-20-110)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020.
  
  

• Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)
  (RFA-AI-20-004)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 20, 2020
  
  

• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
  (RFA-OD-20-008)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022) All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-OD-20-009)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
  (RFA-OD-20-010)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
  (RFA-OD-20-011)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.